BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6862843)

  • 21. Separation of proteins in concentrated cerebrospinal fluid by two-dimensional electrophoresis in acrylamide gel.
    Wright GL
    Clin Chem; 1971 May; 17(5):430-2. PubMed ID: 4102254
    [No Abstract]   [Full Text] [Related]  

  • 22. Guillain Barre syndrome-electrodiagnostic features and therapeutic observations.
    Shankar V; Bhanu K; Sayeed ZA
    J Assoc Physicians India; 1995 Oct; 43(10):670-2. PubMed ID: 8773000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmapheresis versus plasma perfusion in acute Guillain-Barré syndrome.
    Morosetti M; Meloni C; Taccone Gallucci M; Rossini PM; Felicioni R; Palombo G; Boccasena P; Casciani CU
    ASAIO J; 1994; 40(3):M638-42. PubMed ID: 8555592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal protein patterns in blood serum and cerebrospinal fluid detected by capillary electrophoresis.
    Ivanova M; Tzvetanova E; Jetcheva V; Kilár F
    J Biochem Biophys Methods; 2002; 53(1-3):141-50. PubMed ID: 12406596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of chronic inflammatory demyelinating polyradiculoneuropathy complicated by phrenic nerve palsy].
    Kawakami T; Sekijima Y; Tokuda T; Yamazaki M; Yanagisawa N
    Rinsho Shinkeigaku; 1998 Feb; 38(2):118-21. PubMed ID: 9619073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy.
    Molenaar DS; Vermeulen M; de Haan R
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):84-9. PubMed ID: 9436733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid proteins in neurological diseases. Studies on agar gel electrophoresis protein profiles.
    Jensen K
    Acta Neurol Scand Suppl; 1978; 70():1-268. PubMed ID: 81584
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of chronic, motor, axonal polyneuropathy successfully treated by immunoadsorption].
    Nagane Y; Utsugisawa K; Kin M; Ohi K; Tohgi H
    Rinsho Shinkeigaku; 1998 Jan; 38(1):51-3. PubMed ID: 9597911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study on therapeutic plasmapheresis--mechanism of its efficacy, indications, and the clinical application. k. Nervous system diseases].
    Sato T; Utsumi H; Kagamihara Y
    Nihon Rinsho; 1984 Aug; 42(8):1908-13. PubMed ID: 6513058
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of therapeutic plasmapheresis in demyelinating neurologic disorders.
    Tindall RS; Rollins JA
    South Med J; 1986 Aug; 79(8):991-7. PubMed ID: 3016910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early electrophysiological findings in acute inflammatory demyelinating polyradiculoneuropathy variant of Guillain-Barre syndrome in the Pakistani population - a comparison with global data.
    Wali A; Kanwar D; Khan SA; Khan S
    J Peripher Nerv Syst; 2017 Dec; 22(4):451-454. PubMed ID: 29091318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasmapheresis in neurological diseases].
    Oikarinen R
    Duodecim; 1990; 106(7):553-4. PubMed ID: 1670211
    [No Abstract]   [Full Text] [Related]  

  • 33. Experience with plasmapheresis in 153 neurologic patients.
    Dau PC; Miller RG; Denys EH
    Int J Artif Organs; 1982 Jan; 5(1):37-46. PubMed ID: 7068264
    [No Abstract]   [Full Text] [Related]  

  • 34. Patients treated with plasmapheresis: a case review from University Hospital of the Canary Islands.
    Rufino Hernández M; Escamilla Cabrera B; Alvarez Sosa D; García Rebollo S; Losada Cabrera M; Hernández Marrero D; Alvarez Gonzalez A; Torres Ramírez A; Maceira Cruz B; Lorenzo Sellares V
    Nefrologia; 2011; 31(4):415-34. PubMed ID: 21738245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmapheresis combined with lymphocytapheresis and cytotoxic drugs as a therapeutic modality in neuroimmunological diseases.
    Valbonesi M; Montani F; Florio G; Zerbi D; Beltramelli A
    Ital J Neurol Sci; 1984 Mar; 5(1):35-40. PubMed ID: 6329999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
    Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
    Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barré syndrome.
    Ropper AH; Wijdicks EF; Shahani BT
    Arch Neurol; 1990 Aug; 47(8):881-7. PubMed ID: 2375695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of M-proteins in the cerebrospinal fluid].
    Horie Y; Otake H; Isoyama S; Sugano T
    Rinsho Byori; 1974 Oct; 22(10 Suppl):177. PubMed ID: 4475781
    [No Abstract]   [Full Text] [Related]  

  • 39. [Plasmapheresis in neurology. Critical analysis of indications and protocols].
    Seggia JC; Abreu P
    Arq Neuropsiquiatr; 1992 Sep; 50(3):324-8. PubMed ID: 1308410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Selected clinical problems in Guillain-Barré syndrome].
    Piłkowska E
    Neurol Neurochir Pol; 1981; 15(1):31-7. PubMed ID: 7254471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.